Modern methods to predict costs for the treatment and management of head and neck cancer patients: Examples of methods used in the current literature

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 16, Issue 2, 2008, Pages 113-116

  Wineland, Andre M ^a   Stack Jr , Brendan C ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Costs; Head and neck cancer; Head and neck squamous cell carcinoma; Methods

Indexed keywords

FLUORODEOXYGLUCOSE F 18; HERMES ANTIGEN;

CANCER PALLIATIVE THERAPY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; METHYLATION; MOUTH CANCER; OROPHARYNX CANCER; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENSITIVITY AND SPECIFICITY; STENT;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FORECASTING; HEAD AND NECK NEOPLASMS; HEALTH CARE COSTS; HUMANS;

EID: 40449126790     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3282f5520a     Document Type: Review

References (7)

1. Epstein JP, Knight TK, Epstein JB, et al. Cost of care for early- and late-stage oral and pharyngeal cancer in the California Medicaid population. Head Neck 2007; 29:948-958. Treating early-stage OSCC is 36% less expensive than late-stage in a California Medicaid population.
2. O'Donnell CA, Gray J, Hodgson H, et al. A cost comparison of photodynamic therapy and metallic stents in the palliation of oesophageal cancer. Photodiagn Photodyn Ther 2007; 4:65-70. PDT is a cost-effective palliative care treatment modality in oesophageal cancer. Although PDT is associated with longer survival, quality of life is unaffected.
3. Yabroff RK, Davis WW, Lamont EB, et al. Patient time costs associated with cancer care. JNCI 2007; 99:14-23. The authors examined the cost of care with regard to a patient's time.
4. Preuss SF, Quante G, Semrau R, et al. An analysis of surgical complications, morbidity, and cost calculation in patients undergoing multimodal treatment for operable oropharyngeal carcinoma. Laryngoscope 2007; 117:101-105. Although more expensive, the multimodal approach to oropharyngeal carcinoma provides a limited number of complications, tolerable morbidity, and higher survival rates.
5. 18F]-2-flurodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 2007; 117:1173-1179. The ability to merge cellular metabolic activity of PET with the anatomical detail obtained through CT provides a powerful tool to initially evaluate patients with the potential of changing management by detecting distant metastasis or synchronous lesions.
6. Franzmann EJ, Reategui EP, Pedroso F, et al. Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2007; 16:1348-1355. Physical examine-based screening has limited sensitivity and specificity and poor ability to detect occult disease. Molecular markers used to screen high-risk populations show promise, especially solCD44, which has shown high specificity and sensitivity in a small high-risk population.
7. Hollenbeak CS, Stack BC, Daley SM, et al. Using comorbidity indexes to predict costs for head and neck cancer. Arch Otolaryngol Head Neck Surg 2007; 133:24-27. This paper illustrates that comorbidity indexes for head and neck cancer may be useful in predicting costs and outcome in an elderly population.